Multiple sclerosis (MS)
13 results
1 - 13
Alemtuzumab more effective than interferon for multiple sclerosis- After 15 years, 50% of patients with optic neuritis developed MS (ONTT)
- Oral fingolimod reduces MS recurrence, appears to increase cancer risk
- OB outcomes for those with MS and epilepsy similar to general population; diabetics worse
- Medical marijuana for various neurologic conditions: mixed outcomes